RXRX Today - Jul 13: Stock Takes a Dip
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
RXRX Today - Jul 13: Stock Takes a Dip
-
ナレーター：
-
著者：
So, what happened? Well, RXRX got smoked today, dipping down a bit. You could say it was a slow bleed, and honestly, it didn’t get a ton of love from the market. There was a decent amount of trading, but it was way below the usual volume. People seemed to be hitting the sell button pretty quickly.
Now, why did this happen? It looks like there’s some chatter about whether the stock is fully priced. An article from Simply Wall Street pointed out that while the company is making strides in its clinical progress, some folks are questioning if the current price reflects its true value. That uncertainty can scare investors off. Plus, there’s a piece from the Motley Fool calling out RXRX and other stocks as beaten-down but not worth buying right now. When you hear that kind of talk, it can definitely shake up confidence.
On the flip side, Cathie Wood just made some moves, snagging a few stocks that she thinks are bargains. But it’s unclear if RXRX made her shopping list. So, while some big names are out there hunting for deals, it seems like RXRX was left behind today.
Just a quick heads up: Recursion is still pushing through its clinical trials, which could be a game-changer if things go well. So, keep an eye on that, ’cause it could shift the narrative if they hit some big milestones down the line.
Alright, that wraps it up for today! RXRX had a rough day, but that’s how the market rolls sometimes. Remember, this is just info for you to chew on, not financial advice. Stay savvy out there, and I’ll catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません